Illumina Inc

ILMN

Company Profile

  • Business description

    Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina’s high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2023 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

  • Contact

    5200 Illumina Way
    San DiegoCA92122
    USA

    T: +1 858 202-4500

    E: [email protected]

    https://www.illumina.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Diagnostics & Research

    Fiscal Year End

    31 December 2024

    Employees

    9,300

Illumina Inc News & Analysis

funds

Profitable lessons from the bad timing of other investors

Patience rewards, greed kills.
stocks

33 undervalued US stocks

Here’s the new list of Morningstar’s top analyst picks for Q1 2023.
stocks

The stocks to watch this decade

Big data and analytics, networks and computer systems, energy and medicine: just some of the big tech themes for the 2020s. Here are the names that stand to benefit.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,450.9064.30-0.76%
CAC 407,240.7013.720.19%
DAX 4019,068.7635.120.18%
Dow JONES (US)43,910.98382.15-0.86%
FTSE 1008,035.129.350.12%
HKSE19,823.4523.43-0.12%
NASDAQ19,281.4017.36-0.09%
Nikkei 22538,721.66654.43-1.66%
NZX 50 Index12,674.4974.87-0.59%
S&P 5005,983.9917.36-0.29%
S&P/ASX 2008,193.4062.20-0.75%
SSE Composite Index3,439.2817.310.51%

Market Movers